Ajenthen Ranjan
Ajenthen Ranjan
Steno Diabetes Center Copenhagen
Bekræftet mail på regionh.dk
Citeret af
Citeret af
Low-carbohydrate diet impairs the effect of glucagon in the treatment of insulin-induced mild hypoglycemia: a randomized crossover study
A Ranjan, S Schmidt, C Damm-Frydenberg, I Steineck, TR Clausen, ...
Diabetes Care 40 (1), 132-135, 2017
Short‐term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open‐label crossover trial
A Ranjan, S Schmidt, C Damm‐Frydenberg, JJ Holst, S Madsbad, ...
Diabetes, Obesity and Metabolism 19 (10), 1479-1484, 2017
Effects of subcutaneous, low‐dose glucagon on insulin‐induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes
A Ranjan, S Schmidt, S Madsbad, JJ Holst, K Nørgaard
Diabetes, Obesity and Metabolism 18 (4), 410-418, 2016
Effects of alcohol on plasma glucose and prevention of alcohol‐induced hypoglycemia in type 1 diabetes—A systematic review with GRADE
R Tetzschner, K Nørgaard, A Ranjan
Diabetes/Metabolism Research and Reviews 34 (3), e2965, 2018
Sensor-augmented insulin pumps and hypoglycemia prevention in type 1 diabetes
I Steineck, A Ranjan, K Nørgaard, S Schmidt
Journal of Diabetes Science and Technology 11 (1), 50-58, 2017
Inheritance of the chronic myeloproliferative neoplasms. A systematic review
A Ranjan, E Penninga, AM Jelsig, HC Hasselbalch, OW Bjerrum
Clinical genetics 83 (2), 99-107, 2013
Low versus high carbohydrate diet in type 1 diabetes: A 12‐week randomized open‐label crossover study
S Schmidt, MB Christensen, N Serifovski, C Damm‐Frydenberg, ...
Diabetes, Obesity and Metabolism 21 (7), 1680-1688, 2019
Dual‐hormone treatment with insulin and glucagon in patients with type 1 diabetes
HK Reiband, S Schmidt, A Ranjan, JJ Holst, S Madsbad, K Nørgaard
Diabetes/metabolism research and reviews 31 (7), 672-679, 2015
An artificial pancreas for automated blood glucose control in patients with type 1 diabetes
S Schmidt, D Boiroux, A Ranjan, JB Jørgensen, H Madsen, K Nørgaard
Therapeutic delivery 6 (5), 609-619, 2015
Effects of preceding ethanol intake on glucose response to low-dose glucagon in individuals with type 1 diabetes: a randomized, placebo-controlled, crossover study
A Ranjan, K Nørgaard, R Tetzschner, IIK Steineck, TR Clausen, JJ Holst, ...
Diabetes Care 41 (4), 797-806, 2018
Cross-validation of a glucose-insulin-glucagon pharmacodynamics model for simulation using data from patients with type 1 diabetes
SL Wendt, A Ranjan, JK Møller, S Schmidt, CB Knudsen, JJ Holst, ...
Journal of diabetes science and technology 11 (6), 1101-1111, 2017
Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study
IIK Steineck, A Ranjan, S Schmidt, TR Clausen, JJ Holst, K Nørgaard
Diabetologia 62 (4), 582-592, 2019
Comparison of Continuous Glucose Monitoring Accuracy Between Abdominal and Upper Arm Insertion Sites
IIK Steineck, Z Mahmoudi, A Ranjan, S Schmidt, JB Jørgensen, ...
Diabetes technology & therapeutics 21 (5), 295-302, 2019
Effect of Ethanol Intoxication on the Antihypoglycemic Action of Glucagon
L Ekhlaspour, D Mondesir, A Esmaeili, M Hillard, RZ Jafri, M Sinha, ...
DIABETES 66, A96-A96, 2017
Relationship between Optimum Mini‐doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes–A Simulation Study
A Ranjan, SL Wendt, S Schmidt, S Madsbad, JJ Holst, H Madsen, ...
Basic & Clinical Pharmacology & Toxicology 122 (3), 322-330, 2018
Glucagon treatment in type 1 diabetes-with focus on restoring plasma glucose during mild hypoglycemia.
A Ranjan
Danish medical journal 65 (2), 2018
Myeloproliferative neoplasms in Danish twins
MA Andersen, OW Bjerrum, A Ranjan, V Skov, TA Kruse, M Thomassen, ...
Acta haematologica 139 (3), 195-198, 2018
Simulating clinical studies of the glucoregulatory system: in vivo meets in silico
SL Wendt, A Ranjan, JK Møller, CB Knudsen, JJ Holst, S Madsbad, ...
Technical University of Denmark-Technical Report, 2017
Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump–Treated Type 1 Diabetes
AG Ranjan, SV Rosenlund, TW Hansen, P Rossing, S Andersen, ...
Diabetes Care 43 (11), 2882-2885, 2020
28-LB: Improved Time in Glucose Range over One Year Is Associated with Reduced Albuminuria in Sensor-Augmented Insulin Pump–Treated Type 1 Diabetes
Diabetes 69 (Supplement 1), 2020
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20